Printer Friendly

Diagnostic Value of Ultrasound and Tc-99m MIBI scintigraphy and SPECT/CT for Pre-operative Localization of Parathyroid Adenoma in Patients with Primary Hyperparathyroidism: A Single-Center Comparative Study/Operasyon Oncesi Paratiroid Adenomlarinin Yerini Saptamada Ultrason ve Tc-99m MIBI sintigrafisi ve SPECT/CT Incelemenin Tanisal Degeri.

INTRODUCTION

Hyperparathyroidism is defined as an increased level of parathyroid hormone and can be classified as primary, secondary, and tertiary hyperparathyroidism. Over functioning of the gland itself due to adenoma or hyperplasia is classified as primary hyperparathyroidism (PHPT), and approximately 80% of PHPT cases occurs due to parathyroid adenomas (1). Although PHPT typically involves the musculoskeletal system, particularly bones, the disease can manifest with diverse clinical symptoms and findings, including peptic ulceration, alterations in the mental status, and nephrolithiasis (1, 2). Traditionally, conventional bilateral neck exploration was the method of choice for the operation, but there has been a recent trend toward minimally invasive parathyroidectomy (MIP), mostly given the technological advancements of the pre-operative imaging methods (3-6). The success of MIP has been endorsed by many studies, showing that while MIP has comparable curative rates with the traditional approaches, it also offers lower complication rates, reduced costs, substantially shorter operation and post-operative hospitalization time, and better cosmetic results (4-6).

Conventional ultrasound (US) and 99 mTc-MIBI scintigraphy are the most widely used modalities in the pre-operative evaluation of the patients with suspicion of PHPT secondary to parathyroid disease. To date, many studies have investigated and favored the diagnostic value of these two methods in detecting parathyroid adenomas, although a considerably wide range of sensitivity has been reported (7-11).

Herein, we aimed to assess and compare the diagnostic value of pre-operative US and 99 mTc-MIBI planar scintigraphy in combination with single-photon-emission computed tomography/computed tomography (SPECT/CT) for the pre-operative evaluation of PHPT.

METHODS

A local ethics committee approved this retrospective study, which was carried out from January 2006 to January 2018. A need of informed consent was waived by the ethic board for the retrospective review of the clinical and radiologic data of patients. A total of 60 patients with clinically and biochemically proven PHPT (increased intact PTH, increased serum calcium, and normal kidney functions) were included in the study. All patients had to have a pre-operative US and 99 mTc-MIBI+SPECT/CT scan to be eligible for the study. Patients with recurrent or persistent hyperparathyroidism, a history of former thyroid or parathyroid operation, and a history of any neck malignancy were excluded from the study.

99 mTc-MIBI+SPECT/CT and US examinations

Dual-phase parathyroid scintigraphy using the 99 mTc-MIBI was utilized for all patients. First, 740 MBq of 99 mTc-MIBI were given to patients, and then immediate (at 10 minutes) and delayed (at 180 minutes) images were obtained. The immediate phase comprised static images of the chest on the anterior plane at 10 minutes, and static images of the neck on the anterior, left and right, and left oblique planes at 5 minutes after the injection. All acquisitions were handled using a low-energy, high-resolution parallelhole collimator with a matrix size 256X256 and a 1.85X zoom level. Afterward, static anterior left and right oblique plane images were obtained from a distance of 10 cm from the patient's skin using a five pinhole collimator mm in diameter (matrix size, 256X256; 2.19X zoom). A dual-head gamma camera (Siemens) that was adjusted to 140 keV and had a 10% width (range, 133-147 keV) was used for all planar imaging. Approximately 1 hour after the 99 mTc-MIBI administration, the neck and the upper thorax of the patients were examined with a SPECT/CT (SIEMENS INTEVO 6 xSPECT) equipped with a dual-head gamma camera (matrix size, 128X128), which was combined with the CT system positioned on the same gantry. The CT system parameters were 2.5 mA and 130 kVp, 2X2.5 mm collimation, and 10 mm sections reconstructed in a 256X256 matrix. The delayed images consisted of the same acquisitions as for the immediate phase 5 min pinhole and parallel hole images.

Two discriminative features of parathyroid adenomas were used when interpreting scintigraphy examinations: 1) Both thyroid parenchyma and parathyroid adenomas show the 99 mTc-MIBI uptake during the early phases; however, normal thyroid gland showed faster wash-out compared to the adenomas, while adenomas showed fixed 99 mTc-MIBI uptake during the later phases; and 2) occasionally, parathyroid adenomas might also show more prominent tracer uptake during the early phases (12). Figure 1 shows a 99 mTc-MIBI planar scintigraphy+SPECT/CT image of a patient with adenoma.

The same observer with over 20 years of thyroid and parathyroid ultrasound experience performed all US examinations. The patients were directed to lay in a comfortable supine position, hyperextending their necks for the US evaluation. The operator performed all examinations with the same device (LOGIQ E9 with XDclear, General Electric (GE) Healthcare, Wauwatosa, WI, USA) using a linear array transducer (ML6-15) with a frequency range 12-15 MHz. The observer examined the neck putting a particular focus on posterior neighborhoods of the upper and the lower parts of the thyroid lobes. Given the more diverse presentation of the lower quadrant adenomas, the observer delicately explored the paratracheal regions, the area around the carotid artery, and deep regions of the neck and superior mediastinum using the oblique craniocaudal view. The observer identified parathyroid adenomas by their oval-shaped, solid, and hypoechogenic appearance compared to thyroid parenchyma. In equivocal cases, a Doppler US was also applied to identify the feeder artery, which commonly stems from the inferior thyroid artery and giving it an arc- or rim-like vascular appearance (10). The observer noted whether the adenoma was present, and if present, the exact location of the lesion, as located in the right-upper, right-lower, left-upper, and left-lower pole of the parathyroid gland. Moreover, if more than one lesion was detected, the observer also noted that lesion. The incidental or previously known pathologies of the thyroid gland that were identified during the examination were also indicated for a further diagnostic workup.

Surgery

All the procedures were performed under general anesthesia. Patients with solitary parathyroid adenoma and without additional thyroid pathology were operated by one of the three surgeons in our institute using minimal invasive parathyroidectomy in light of the pre-operative US and 99 mTc-MIBI planar scintigraphy+SPECT/CT. The surgeons applied total or unilateral thyroidectomy operation with a more extensive surgical approach in appropriate cases. The adenoma location according to US and scintigraphy findings was presented as four quadrants: the right-upper, right-lower, left-upper, and left-lower quadrant. The surgeons started the operation by placing an approximately 2-3 cm transverse incision line over the proper localization of the adenoma. To prevent damage, the recurrent laryngeal nerve was carefully monitored during the procedure. If a thyroid operation was necessary or the disease was multiglandular, a total thyroidectomy with a more extensive neck exploration was performed rather than MIP. The success of the operation was determined by measuring the intraoperative intact parathyroid hormone levels in which the reduction of the PTH <50% was accepted as an adequate removal. All of the patients were discharged within 2 days after the operation, and no significant complications were encountered.

Statistical Analysis

All statistical analyses were performed using the Statistical Package for Social Sciences 21 version (IBM Corp.; Armonk, NY, USA). All continuous variables were presented as the mean standard deviation unless otherwise specified. Pre- and post-operative PTH, Ca, and p levels were compared using the paired Student's t-test. The sensitivity, specificity, and diagnostic accuracy of the US and 99 mTc-MIBI scintigraphy were calculated accepting the surgical pathology as a reference method for both per lesions. The true positive (TP) result was defined as correct identification of the parathyroid adenoma side and the level (i.e., if the imaging study identified a lesion in the right-upper quadrant of the disease and the surgery confirmed the presence, then the diagnosis was classified as TP). If the pre-operative imaging correctly assessed the side but incorrectly interpreted the level, that case was accepted as the false negative (FN). False-positive results were defined as a pre-operative positive lesion in the relevant location despite negative surgical findings. The following formulas were used the calculate sensitivity, TP/(TP+FN); specificity, TN/(TN+FP); and diagnostic accuracy, (TP +TN)/(TP+TN+FP+FN).

RESULTS

A total of 60 patients, 9 male (15%) and 51 female (85%), with a mean age of 54.78+12.80 years were enrolled in the study. Detailed demographics, and pre- and post-operative biochemical and histological findings of the patients are listed in Table 1. Among 60 patients, 54 had solitary parathyroid adenoma (90%), while five patients (8.3%) had a multiglandular disease, and all of them were hyperplasia. All patients with solitary parathyroid adenoma underwent MIP, except for patients who had a combination of thyroidectomy and parathyroidectomy during the same session. Pre-operative US identified 48/54 (88.9%) of the solitary adenoma, while pre-operative 99 mTc-MIBI planar scintigraphy +SPECT/CT was able to identify all solitary adenomas except for two patients (96.3%). The solitary adenoma missed by the scintigraphy was detected on the pre-operative US. Hence, the combination of pre-operative US and 99 mTc-MIBI planar scintigraphy+SPECT/CT correctly identified all the solitary parathyroid adenomas. Among five patients with multiglandular disease, one had right upper and lower, one had right lower and left upper, two had right lower and left lower, and one had a four-quadrant disease. US was able to identify all multiglandular involvements in four out of five patients (80%) except for the patients with glandular hyperplasia involving all quadrants of the gland. Among these five patients, 4 had parathyroid hyperplasia, and one had two parathyroid adenomas. US was able to correctly identify two out of four of these glandular involvements, yet given to our methodology, this case was accepted as FN. The 99 mTc-MIBI planar scintigraphy+SPECT/CT detected the pathology in three out of five patients (60%) with multiglandular disease. The 99 mTc-MIBI planar scintigraphy+SPECT/CT also could not detect all quadrants in patients with multiglandular disease involving all quadrants and entirely missed the pathology in the other patient. In one patient, both the US and 99 mTc-MIBI planar scintigraphy identified a solitary nodule in the right parathyroid gland, yet surgical exploration could not detect abnormal parathyroid tissue. This patient was scheduled for a follow-up after the operation. Table 2 demonstrates the sensitivity and diagnostic accuracy of the US, 99 mTc-MIBI planar scintigraphy+SPECT/CT, and a combination of these modalities for solitary parathyroid adenoma; Table 3 shows findings of the imaging modalities and the final results of the pathological specimen for multiglandular disease; and Table 4 shows an overall sensitivity and diagnostic accuracy of the US and 99 mTc-MIBI planar scintigraphy+SPECT/CT in detecting parathyroid pathology.

DISCUSSION

In the present study, we demonstrated that while the 99 mTc-MIBI planar scintigraphy+SPECT/CT had a slightly better sensitivity (91.5% vs. 88.1%) and diagnostic accuracy (90% vs. 86.6%) compared to US in identifying parathyroid pathology in patients with PHPT, both of the methods showed sufficient success in accurately determining the location of the pathology. Furthermore, a combination of these methods provided an even better diagnostic value (diagnostic accuracy 96.6% and sensitivity 98.3%) for the pre-operative evaluation of the parathyroid lesions.

Ultrasound (US) and 99 mTc-MIBI planar scintigraphy are the standard imaging methods for the pre-operative assessment in the patients with PPTH. In the past century, pre-operative utilization of these modalities was deemed unnecessary for the evaluation of parathyroid adenoma since the primary approach to parathyroid adenoma involved a bilateral conventional surgical exploration of the neck (3, 13). However, the main trend in the surgical approach for parathyroid adenomas has shifted toward minimally invasive procedures substantially depending on the pre-operative imaging studies (4-6). Many studies have explored the diagnostic value and the role of the US, 99 mTc-MIBI planar scintigraphy, and also the 99 mTc-MIBI planar scintigraphy+SPECT/CT in the pre-operative investigations of the patient with PHPT.

The reported sensitivity of US has considerably varied among the studies. In the present study, the overall sensitivity of US was 88.1%, which was favorably comparable to most of the previous reports with a reported sensitivity range 44%-90% (14-21). We suggest that several factors might have led to this wide gap between the studies. First, US is considerably an operator-dependent modality; hence, the experience of the operator seems to be a one of the critical factors resulting in this difference (20, 22). Second, the previous works were conducted within a substantially long timeline; therefore, the technological advancements of the US units might also play an essential role in this issue (14-21).

Furthermore, the location of the parathyroid adenomas might also lead to this difference. It has been well-known that ectopic locations such as the upper mediastinum and the retroesophageal area, or deep location of the adenoma, pose particular challenges for the sonographic evaluation (23, 24). In our study, only two of the 59 patients with surgically proven parathyroid pathology had adenomas located in the upper mediastinum, and US failed to detect both of these lesions, in line with the several previous works (4, 23, 24).

Besides from the evaluation of the parathyroid lesions, US also had several advantages over the 99 mTc-MIBI planar scintigraphy+SPECT/CT. First, US has a better spatial resolution, which allowed the operator to investigate potential thyroid pathology simultaneously, and this advantage might be quite helpful in endemic areas for thyroid disease (25). For instance, 31.7% of the patients in our study cohort underwent total or unilateral thyroidectomy in combination with parathyroid surgery for their additional thyroid pathology. As in conjunction with the several previous works, US showed a better diagnostic performance in multiglandular disease compared to scintigraphy, and correctly detected all the pathological quadrants in four out of five of the patients (80%) (25-27). US is also a cost-effective, portable, non-radiation-bearing modality with widespread availability compared to scintigraphy. Moreover, US also could increase the confidence of the surgeons by confirming scintigraphic findings and, hence, aid surgeons tailoring the best surgical strategy for MIP.

Despite US advantages, the 99 mTc-MIBI planar scintigraphy is commonly accepted as the gold standard modality for the pre-operative evaluation of patients with PHPT (12). The reported sensitivity and diagnostic accuracy of the 99 mTc-MIBI planar scintigraphy was substantially higher compared to US in the previous works (25-28). The 99 mTc-MIBI planar scintigraphy is also superior to US in detecting ectopic lesions, and in our study, the 99 mTc-MIBI planar scintigraphy+SPECT/CT was able to show two ectopic parathyroid adenomas, where US failed to do so. One of the main disadvantages of the 99 mTc-MIBI planar scintigraphy is its lower spatial and anatomical resolution compared to US, which is currently substantially alleviated by the addition of SPECT/CT to the planar imaging (30). In our study, we did not compare planar imaging with the cross-sectional method, yet the reported diagnostic accuracy of SPECT/CT was higher in previous works (30). In the present work, the main flaw of the 99 mTc-MIBI planar scintigraphy+SPECT/CT was exposed by multiglandular disease in conjunction with the previous reports (25-27). Several authors advocated that dominant increased function of one of the pathological glands in multiglandular disease might reduce the reached tracer to the others, which substantially limits the detection of the glands. Increased expression of a multidrug resistance protein, glycoprotein P, is also considered to limit the MIBI uptake in these patients. P-glycoprotein is coded by the multidrug resistance gene located at the 7th chromosome and results in increased wash-out of the MIBI (30, 31).

There were several limitations to our study. First, the study was retrospectively designed; hence, our findings should be evaluated with precaution. Second, we did not compare SPECT/CT with the planar imaging, as mentioned in the previous paragraphs. Third, we had only two patients with ectopic parathyroid adenoma and five patients with multiglandular disease, which substantially limited us to draw a definite conclusion concerning the diagnostic value of the US and 99 mTc-MIBI planar scintigraphy+SPECT/CT in these patients. Finally, we did not investigate the ability of imaging methods to detect pathology compared to adenomas weight.

CONCLUSION

Ultrasound (US), in the hands of a skilled and experienced operator, and the 99 mTc-MIBI planar scintigraphy+SPECT/CT had separately an excellent diagnostic ability in assessing patients with PHPT in the pre-operative period; however, the combination of these methods showed an even superior diagnostic accuracy and sensitivity reaching up to 96.6% and 98.3, respectively. We highlight that although both of these methods could be separately used as a pre-operative guide for the MIP, their combination should always be preferred.

Acknowledgment: We acknowledge to Professor Dr. Mehmet Onur Demirkol for review and criticism in improving the manuscript and also sharing his invaluable experience and knowledge regarding the nuclear imaging methods used in the study.

Ethics Committee Approval: Ethics committee approval was received for this study from the Ethics Committee of Vehbi Koc American Hospital.

Informed Consent: Informed consent was not taken from patients due to the retrospective nature of the study.

Peer-review: Externally peer-reviewed.

Author Contributions: Concept - B.C.; Design - B.C.; Supervision - B.C.; Resources - B.C.; Data Collection and/or Processing - D.A.; Analysis and/or Interpretation - D.A.; Literature Search - D.A.; Writing Manuscript - B.C., D.A.; Critical Review - B.C.

Conflict of Interest: The authors have no conflict of interest to declare.

Financial Disclosure: The authors declared that this study has received no financial support.

Tesekkur: Profesor Dr. Mehmet Onur Demirkol'a makaleyi gelistiren inceleme ve elestirilerden ve ayrica arastirmada kullanilan nukleer goruntuleme yontemleriyle ilgili paha bicilmez deneyim ve bilgisini paylasmasindan dolayi tesekkur ediyoruz.

Etik Komite Onayi: Bu calisma icin etik komite onayi Vehbi Koc Amerikan Hastanesi Etik Kurulu'ndan alinmistir.

Hasta Onami: Calismanin retrospektif tasarimindan dolayi hasta onami alinamamistir.

Hakem Degerlendirmesi: Dis bagimsiz.

Yazar Katkilari: Fikir - B.C.; Tasarim - B.C.; Denetleme - B.C.; Kaynaklar - B.C.; Veri Toplanmasi ve/veya Islemesi - D.A.; Analiz ve/veya Yorum - D.A.; Literatur Taramasi - D.A.; Yaziyi Yazan - B.C., D.A.; Elestirel Inceleme - B.C.

Cikar Catismasi: Yazarlarin beyan edecek cikar catismasi yoktur.

Finansal Destek: Yazarlar bu calisma icin finansal destek almadiklarini beyan etmislerdir.

REFERENCES

(1.) Potts JT. Diseases of the parathyroid gland and other hyper- and hypocalcemic disorders. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS, eds. Harrison's Principles of Internal Medicine, 11th edn. New York: McGraw Hill, 1987; p.1870-1889.

(2.) Fraser WD. Hyperparathyroidism. Lancet 2009; 374: 145-58.

(3.) Satava RM, Beahrs OH, Scholz DA. Success rate of cervical exploration for hyperparathyroidism. Arch Surg 1975; 110: 625-8

(4.) Smit PC, Rinkes IHM, van Dalen A, van Vroonhoven TJMV. Direct, minimally invasive adenomectomy for primary hyperparathyroidism. An alternative to conven- tional neck exploration? Ann Surg 2000; 231: 559-65.

(5.) Ulanovski D, Feinmesser R, Cohen M, Sulkes J, Dudkiewicz M, Shpitzer T. Preoperative evaluation of patients with parathyroid adenoma: role of high resolution ultrasonography. Head Neck Surg 2002; 24: 1-5.

(6.) Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002; 235: 665-70.

(7.) Nichols KJ, Tomas MB, Tronco GG, Rini JN, Kunjummen BD, Heller KS, et al. Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings. Radiology 2008; 248: 221-32.

(8.) Elaraj DM, Sippel RS, Lindsay S, Sansano I, Duh QY Clark OH, et al. Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? Arch Surg 2010; 145:578-81.

(9.) Berber E, Parikh RT, Ballem N, Garner CN, Milas M, Siperstein AE. Factors contributing to negative parathyroid localization: an analysis of 1000 patients. Surgery 2008; 144: 74-9.

(10.) Johnson NA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. AJR Am J Roentgenol 2007; 188: 1706-15.

(11.) Kim, YI, Jung YH, Hwang KT, Lee HY. Efficacy of 99m Tc-sestamibi SPECT/CT for minimally invasive parathyroidectomy: comparative study with 99m Tc-sestamibi scintigraphy, SPECT, US and CT. Ann Nucl Med 2012; 26: 804-10.

(12.) Hindie E, Ugur O, Fuster D, ODoherty M, Grassetto G, et al. EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging 2009; 36: 1201-16.

(13.) van Heerden JA, Grant CS. Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg 199; 15: 688-92.

(14.) Chapuis Y Fulla Y Bonnichon P, Tarla E, Abboud B, et al. Values of ultrasonography, sestamibi scintigraphy, and intraoperative measurement of 1-84 PTH for unilateral neck exploration of primary hyperparathyroidism. World J Surg 1996; 20: 835-40.

(15.) Mazzeo S, Caramella D, Lencioni R, Molea N, De Liperi, A, et al. Comparison among sonography, double- tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions. AJR Am J Roentgenol 1996; 166: 1465-70.

(16.) Geatti O, Shapiro B, Orsolon PG, Proto G, Guerra UP, Antonucci F, et al. Localization of parathyroid enlargement: experience with technetium99m methoxyisobutyl- isonitrile and thallium-201 scintigraphy ultrasonography and com- puted tomography. Eur J Nucl Med 1994; 21: 17-22.

(17.) Hindie E, Melliere D, Simon D, Perlemuter L, Galle P. Primary hyperparathyroidism: is technetium99m-sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged para- thyroid glands before surgery? J Clin Endocrinol Metab 1995; 80: 302-7.

(18.) Bonjer HJ, Bruining HA, Valkema R, Lameris JS, de Herder WW, van der Harst E, et al. Single radionuclide scintigraphy with 99mtechnetium-sestamibi and ultrasonography in hyperparathyroidism. Eur J Surg 1997; 163: 27-32.

(19.) Staudenherz A, Abela C, Niederle B, Steiner E, Helbich T, Puig S, et al. Comparison and histopathological correlation of three parathyroid imaging method in a population with a high prevalence of concomitant thyroid disease. Eur J Nucl Med 1997; 24: 143-9.

(20.) De Feo ML, Colagrande S, Biagini C, Tonarelli A, Bisi G, Vaggelli L, et al. Parathyroid glands: combination of (99m) Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 2000; 214: 393-402.

(21.) Tunca F, Akic, M, Iscan Y Cem IS, Giles YS, Terzioglu T. The impact of combined interpretation of localization studies on image-guided surgical approaches for primary hyperparathyroidism. Minerva Endocrinol 2017; 42: 213-22.

(22.) Lloyd MN, Lees WR, Milroy EJ. Preoperative localization in primary hyperparathyroidism. Clin Radiol 1990; 41: 239-43.

(23.) van Dalen A, Smit CP, van Vroonhoven TJ, Burger H, de Lange EE. Minimally invasive surgery for solitary parathyroid adenomas in patients with primary hyperparathyroidism.

(24.) Gilat H, Cohen M, Feinmesser R, Benzion J, Shvero J, Segal K, et al. Minimally invasive procedure for resection of a parathyroid adenoma: the role of preoperative high[cross product]resolution ultrasonography. J Clin Ultrasound 2005; 33: 283-7.

(25.) Alexandrides TK, Kouloubi K, Vagenakis AG, Yarmenitis S, Spyridonidis T Vassilakos P, et al. The value of scintigraphy and ultrasonography in the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism and concomitant thyroid disease. Hormones (Athens) 2006; 5: 42-51.

(26.) Xue J, Liu Y Ji T, Zhao A, Liang Y Deng H, et al. Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia. Nucl Med Commun 2018; 39: 1129-37.

(27.) Wakamatsu H, Noguchi S, Yamashita H, Yamashita H, Tamura S, Jinnouchi S, et al. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with 99m Tc-MIBI, 201 Tl, MRI and US. Eur J Nucl Med 2001; 28: 1817-27.

(28.) Akbaba G, Berker D, Isik S, Aydin Y Ciliz D, Peksoy I, et al. A comparative study of pre-operative imaging methods in patients with primary hyperparathyroidism: ultrasonography, 99mTc sestamibi, single photon emission computed tomography, and magnetic resonance imaging. J Endocrinol Invest 2012; 35: 359-64.

(29.) Treglia G, Sadeghi R, Schalin--Jantti C, Caldarella C, Ceriani L, et al. Detection rate of 99mTc-MIBI single photon emission computed tomography (SPECT)/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis. Head Neck 2016; 38: 2159-72.

(30.) Alenezi SA, Asa'ad SM, Elgazzar AH. Scintigraphic parathyroid imaging: Concepts and new developments. Res Rep Nucl Med 2015; 5: 9-18.

(31.) Palestro CB, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med 2005; 35: 266-76.

Bulent Colakoglu (1)[iD], Deniz Alis (2)[iD]

(1) Clinic of Radiology, Vehbi Koc Foundation American Hospital, Istanbul, Turkey

(2) Department of Radiology, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey

Cite this article as: Colakoglu B, Alis D. Diagnostic Value of Ultrasound and Tc-99m MIBI scintigraphy and SPECT/CT for Pre-operative Localization of Parathyroid Adenoma in Patients with Primary Hyperparathyroidism: A Single-Center Comparative Study. JAREM 2019; 9(3): 115-20.

ORCID IDs of the authors: B.C. 0000-0003-1268-2654; D.A. 0000-0002-7045-1793.

Corresponding Author / Sorumlu Yazar: Bulent Colakoglu, E-mail / E-posta: blntc@yahoo.com

Received Date / Gelis Tarihi: 21.12.2018 Accepted Date / Kabul Tarihi: 14.01.2019

DOI: 10.5152/jarem.2019.2719
Table 1. Demographics, clinical characteristics, pre- and
post-operative biochemical findings of the study cohort

Variables                         Findings                     p

Age                                57.78+12.80 (26-86)         -
Gender                                                         -
Female                             51 (85%)
Male                                9 (15%)
Pre-operative Ca (mg/dL)           11.08+0.95 (8.6-13.6)       <0.0001
Post-operative Ca (mg/dL)           9.14+0.79 (7.6-11.2)
(**) Pre-operative PTH (pmol/l)   136 (76.75)                  <0.0001
(**) Post-operative PTH (pmol/l)   26 (14.8)
Pre-operative P (mg/dL)             2.70+0.52 (1.9-4.2)        NS
Pre-operative P (mg/dL)             2.71+0.52 (1.9-4)
Multiglandular disease                                         -
Yes                                 5 (8.3%)
No                                 55 (91.7%)
Ectopic Parathyroid Adenoma                                    -
Yes                                 2 (3.3%)
No                                 58 (96.7%)
Thyroid pathology
Present                            19 (31.7%), 13 Nodular
                                  goiter (68.4%), 6 Papillary
                                  carcinoma (31.6%)            -
Absent                             41 (68.3%)
Average weight of the
surgical specimen (mg)            574.9+329.94 (114-2160)      -
Location of the adenoma
Right upper quadrant                4 (7.2%)
Right lower quadrant               21 (38.1%)
Left upper quadrant                 8 (14.5%)
Left lower quadrant                22 (36.7%)

(**) Calculated as median (IQR)

Table 2. Sensitivity and diagnostic accuracy of imaging methods in
detecting solitary parathyroid adenoma

Modalitiy                Sensitivity    Diagnostic
                                        accuracy

Ultrasound                88.9%         87.2%
99mTc MIBI+ SPECT/CT      96.3%         94.5%
99mTc MIBI+ SPECT/CT
combination with US      100%           98.1%

(*) US=ultrasound, 99mTc MIBI+ SPECT/CT=Technetium-99m sestamibi in
combination single photon-emission computed tomography/computed
tomography

Table 3. US, 99mTc MIBI+ SPECT/CT, and surgical pathology findings of
patients with multiglandular disease

Patients  Ultrasound  99mTc MIBI+ SPECT/CT  Histopathology

1         LLQ+ RLQ    LLQ                   RUQ+ RLQ+ LUQ+LLQ
                                            (Hyperplasia)
2         LLQ+LUQ     -                     LLQ+LUQ (Hyperplasia)
3         LLQ+LUQ     LLQ+LUQ               LLQ+LUQ (Hyperplasia)
4         RLQ+LUQ     RLQ+LUQ               RLQ+LUQ (Hyperplasia)
5         RUQ+RLQ     RUQ+RLQ               RUQ+RLQ (adenoma)

RUQ: Right upper quadrant; RLQ: right lower quadrant; LUQ: left upper
quadrant; LLQ: left lower quadrant

Table 4. Overall sensitivity and diagnostic accuracy of imaging methods
in detecting parathyroid disease

Modalitiy               Sensitivity    Diagnostic accuracy

Ultrasound              88.1%          86.6%
99mTc MIBI+ SPECT/CT    91.5%          90%
99mTc MIBI+ SPECT/CT
combination with US     98.3%          96.6%

(*) US=ultrasound, 99mTc MIBI+ SPECT/CT=Technetium-99m sestamibi in
combination single photon-emission computed tomography/computed
tomography
COPYRIGHT 2019 AVES
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Original Investigation / Ozgun Arastirma
Author:Colakoglu, Bulent; Alis, Deniz
Publication:Journal of Academic Research in Medicine
Article Type:Report
Date:Apr 17, 2019
Words:4437
Previous Article:Yazarin Yaniti: Kompanse Kalp Yetmezligi Hastalarinda Ortalama Trombosit Hacmi:Author's Response: The Mean Platelet Volume May Not be Increased in...
Next Article:Comparison of Caveolin-1 and PSA in Prostate Adenocarcinoma/Prostat Adenokarsinomunda Caveolin-1 ve PSA'nin Karsilastirilmasi.
Topics:

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |